Drug Dosing: Infants and Children

Pediatric patients have different body compositions than adults, including variations in body surface area, total body water, and extracellular fluid per kilogram of body weight. These physiological differences affect how drugs distribute and are processed in children's bodies, necessitating adjusted dosages to achieve therapeutic effectiveness while minimizing toxicity.

Pediatric doses are calculated using formulas based on body surface area, age, or weight. Body surface area provides superior correlation with a child's dosage requirements, cardiac output, renal blood flow, and glomerular filtration. These calculation methods help ensure accurate dosing tailored to each child's physiological maturity and organ function.

Neonates have 15-30% more total body water than adults, resulting in a larger volume of distribution for hydrophilic drugs and a smaller volume of distribution for lipophilic drugs. This altered drug distribution in neonates requires careful dosage adjustments to account for these pharmacokinetic differences and ensure appropriate drug concentrations.

Pediatric patients frequently need larger doses than adults due to their larger body surface area and increased volume of distribution. Additionally, children have faster metabolic rates and higher clearance rates for many drugs compared to adults, requiring higher doses to maintain therapeutic drug levels in the bloodstream.

Dosing schedules and frequency require adjustments across distinct age groups including preterm newborns, infants, young children, older children, and adolescents due to differences in drug metabolism and clearance rates. Immature organs in younger children necessitate more frequent dosing adjustments as organ function develops with age.

Pediatric dosage forms predominantly use liquid products equipped with calibrated droppers and added flavors like cherry. These formulations enable precise dosing measurements and improve patient compliance by making medications easier for children to take accurately, reducing the risk of dosing errors.

Neonates and young children have immature organs with reduced metabolic and excretory capacity, necessitating significant dosage adjustments. Pharmacokinetics in pediatric patients differ substantially from adults, affecting drug absorption, distribution, metabolism, and excretion, requiring careful consideration when determining appropriate pediatric doses.